Recently published research from Global Markets Direct, "Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2013", is now available at Fast Market Research
Boston, MA -- (SBWIRE) -- 08/14/2013 -- Global Markets Direct's pharmaceuticals report, "Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the Iroko Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Iroko Pharmaceuticals, LLC's corporate website, SEC filings, investor presentations and featured press releases, both from Iroko Pharmaceuticals, LLC and industry-specific third party sources, put together by Global Markets Direct's team.
- Iroko Pharmaceuticals, LLC - Brief Iroko Pharmaceuticals, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Iroko Pharmaceuticals, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Iroko Pharmaceuticals, LLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Iroko Pharmaceuticals, LLC's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get This Report
- Evaluate Iroko Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Iroko Pharmaceuticals, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Iroko Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Iroko Pharmaceuticals, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Iroko Pharmaceuticals, LLC and identify potential opportunities in those areas.
Companies Mentioned in this Report: Iroko Pharmaceuticals, LLC
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2012
- Kinex Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Arrien Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Inflammatory Bowel Disease - Pipeline Review, H1 2013
- MedImmune, LLC - Product Pipeline Review - 2013
- Kadmon Pharmaceuticals, LLC - Product Pipeline Review - 2012
- Advenchen Laboratories, LLC - Product Pipeline Review - 2013
- Parkinson's Disease - Pipeline Review, H1 2013
- BHR Pharma, LLC - Product Pipeline Review - 2013
- Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013